TrialHead & neck2026

Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

David M Cognetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.